Search results
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks via Yahoo Finance· 2 weeks agoGSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...
GSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...